Kamei, Koichi http://orcid.org/0000-0003-3528-6961
Ogura, Masao
Sato, Mai
Nishi, Kentaro
Shoji, Kensuke
Funaki, Takanori
Ogimi, Chikara
Ito, Shuichi
Funding for this research was provided by:
Taiju Life Social Welfare Foundation
Article History
Received: 9 April 2022
Revised: 13 May 2022
Accepted: 16 May 2022
First Online: 1 August 2022
Declarations
:
: This study was performed in accordance with the Declaration of Helsinki and the ethical guidelines issued by the Ministry of Health, Labour and Welfare of Japan. It was also approved by the ethics committee at the National Center for Child Health and Development (no. 2020–359).
: Written informed consent for publication was obtained from the patients’ guardians (patients aged < 15 years), from patients and their guardians (patients aged 15–20 years), or from the patients only (patients aged ≥ 20 years) prior to study enrollment.
: Koichi Kamei has received research funding from the Terumo Foundation for Life Sciences and Arts and the Public Foundation of Vaccination Research Center; donations from Chugai Pharmaceutical Co. Ltd., Astellas Pharma Inc., Ono Pharmaceutical Co. Ltd, Teijin Pharma Ltd., Shionogi & Co. Ltd., and Otsuka Pharmaceutical Co. Ltd.; and lecture fees from Tanabe Mitsubishi Pharma Corp., Baxter Ltd., and Zenyaku Kogyo Co., Ltd. All other authors have no potential conflicts of interest to disclose. The first draft of the manuscript was written by Koichi Kamei.
Free to read: This content has been made available to all.